Skip to content

Clinical trials

Phase 2 Cholangiocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 2 Clear all

263 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20042
20062
20072
20084
20096
20105
20116
20124
20135
20149
201511
20165
201710
201818
201915
202022
202123
202219
202318
202434
202516
202624

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed87
Recruiting55
Unknown status35
Terminated29
Active, not recruiting24
Not yet recruiting18
Withdrawn12
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)16
Shanghai Zhongshan Hospital10
Fudan University9
Tianjin Medical University Cancer Institute and Hospital8
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest7
Peking Union Medical College Hospital5
Sun Yat-sen University5
The First Affiliated Hospital with Nanjing Medical University5
Memorial Sloan Kettering Cancer Center4
AIO-Studien-gGmbH3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma263
Gallbladder Neoplasms48
Biliary Tract Neoplasms40
Bile Duct Neoplasms26
Carcinoma, Hepatocellular21
Colorectal Neoplasms17
Pancreatic Neoplasms15
Liver Neoplasms12
Neoplasms11
Neoplasm Metastasis10

Trials

Showing 1 to 25 of 263. Each trial links to its page on Pharma Observatory.

163 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.